Cargando…

A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers

BACKGROUND: Patients with a biopsy diagnosis of ductal carcinoma in situ (DCIS) might be diagnosed with invasive breast cancer at excision, a phenomenon known as underestimation. Patients with DCIS are treated based on the risk of underestimation or progression to invasive cancer. The aim of our stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meurs, Claudia J. C., van Rosmalen, Joost, Menke-Pluijmers, Marian B. E., ter Braak, Bert P. M., de Munck, Linda, Siesling, Sabine, Westenend, Pieter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219477/ https://www.ncbi.nlm.nih.gov/pubmed/30327564 http://dx.doi.org/10.1038/s41416-018-0276-6

Ejemplares similares

Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ
por: Meurs, Claudia J. C., et al.
Publicado: (2023)

Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

RE: Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Meurs, Claudia J C, et al.
Publicado: (2020)

Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ
por: Meurs, Claudia J. C., et al.
Publicado: (2022)

Ten years follow-up of histologically benign calcifications in the breast after vacuum-assisted stereotactic biopsy (VASB): Is additional mammographic follow-up warranted?
por: van Bekkum, Sara, et al.
Publicado: (2021)

Underestimation of invasive malignancy on conventional core biopsy of breast
por: Rengabashyam, B, et al.
Publicado: (2009)

Predicting Underestimation of Invasive Cancer in Patients with Core-Needle-Biopsy-Diagnosed Ductal Carcinoma In Situ Using Deep Learning Algorithms
por: Do, Luu-Ngoc, et al.
Publicado: (2022)

Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy
por: Diepstraten, Suzanne C. E., et al.
Publicado: (2013)

Ductal Carcinoma in situ: Underestimation of Percutaneous Biopsy and Positivity of Sentinel Lymph Node Biopsy in a Brazilian Public Hospital
por: Sá, Rafael da Silva, et al.
Publicado: (2021)

Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy
por: Zhou, Hemei, et al.
Publicado: (2022)

Gastric metastasis of breast cancer: A frequent mimicker of primary gastric cancer in breast cancer patients
por: van Bekkum, Sara, et al.
Publicado: (2022)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer
por: Park, Ko Woon, et al.
Publicado: (2022)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Acquired Arteriovenous Fistula of the Breast Following Ultrasound Guided Biopsy of Invasive Ductal Carcinoma
por: Gregg, Adam, et al.
Publicado: (2013)

The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ
por: Yoon, Ga Young, et al.
Publicado: (2020)

miR-210 and miR-152 as Biomarkers by Liquid Biopsy in Invasive Ductal Carcinoma
por: Lopes, Beatriz C., et al.
Publicado: (2021)

Comparison of intraoperative frozen section analysis for sentinel lymph node biopsy during breast cancer surgery for invasive lobular carcinoma and invasive ductal carcinoma
por: Horvath, James W, et al.
Publicado: (2009)

Diagnostic underestimation of atypical ductal hyperplasia and ductal carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of the breast in a Brazilian reference institution
por: Badan, Gustavo Machado, et al.
Publicado: (2016)

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
por: Marrugo-Ramírez, José, et al.
Publicado: (2018)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

A Simple Model to Assess the Probability of Invasion in Ductal Carcinoma In Situ of the Breast Diagnosed by Needle Biopsy
por: Coufal, Oldřich, et al.
Publicado: (2014)

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
por: Lee, Kwan Ho, et al.
Publicado: (2019)

Ductal Carcinoma In Situ Underestimation of Microcalcifications Only by Stereotactic Vacuum-Assisted Breast Biopsy: A New Predictor of Specimens without Microcalcifications
por: Cheung, Yun-Chung, et al.
Publicado: (2020)

Core biopsy as a tool in planning the management of invasive breast cancer
por: Deshpande, Amar, et al.
Publicado: (2005)

Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer
por: Bararia, Akash, et al.
Publicado: (2023)

Ductal carcinoma in situ diagnosed using an ultrasound-guided 14-gauge core needle biopsy of breast masses: can underestimation be predicted preoperatively?
por: Park, Sung Hee, et al.
Publicado: (2014)

Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
por: Buscail, Etienne, et al.
Publicado: (2019)

2892. The Relationship Between Inpatient and Post-discharge Antimicrobial Use at the Hospital-level Across an Integrated Healthcare Network
por: Livorsi, Daniel J, et al.
Publicado: (2019)

Development and Validation of Web-Based Nomograms to Predict Postoperative Invasive Component in Ductal Carcinoma in Situ at Needle Breast Biopsy
por: Lee, Seong Cheol, et al.
Publicado: (2014)

Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001)
por: Zhang, Juliang, et al.
Publicado: (2021)

Underestimation of Invasive Meningococcal Disease in Italy
por: Azzari, Chiara, et al.
Publicado: (2016)

Technique of transurethral needle core biopsy to confirm invasive bladder cancer staging
por: Chłosta, Piotr, et al.
Publicado: (2010)

Emerging Role of Exosomes in Liquid Biopsy for Monitoring Prostate Cancer Invasion and Metastasis
por: Gao, Zhengfan, et al.
Publicado: (2021)

Percutaneous Biopsy Tract Seeding in a Patient with Muscle-invasive Bladder Cancer
por: Gusev, Andrew, et al.
Publicado: (2020)

Omission of axillary sentinel lymph node biopsy in early invasive breast cancer
por: Reimer, Toralf
Publicado: (2023)

Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer
por: Santos, Marcelle Morais dos, et al.
Publicado: (2023)

Contrast-Enhanced Mammographic Features of In Situ and Invasive Ductal Carcinoma Manifesting Microcalcifications Only: Help to Predict Underestimation?
por: Cheung, Yun-Chung, et al.
Publicado: (2021)

Preoperative estimation of the prognosis of invasive breast cancer, based on ultrasound size, core biopsy grade and percutaneous axillary lymph node biopsy
por: Elseedawy, O, et al.
Publicado: (2011)

Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sppcv5rguor6fahsfnkinddg8m